Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Acid inhibitory medication and risk of gastric and oesophageal cancer.

Literature DB >> 17047103

Acid inhibitory medication and risk of gastric and oesophageal cancer.

K E L McColl¹.

Abstract

Entities: Disease

Mesh：

Substances：
Antacids

Year: 2006 PMID： 17047103 PMCID： PMC1860103 DOI： 10.1136/gut.2006.103283

Source DB: PubMed Journal: Gut ISSN： 0017-5749 Impact factor: 23.059

× No keyword cloud information.

13 in total

1. Gastric acid suppression and risk of oesophageal and gastric adenocarcinoma: a nested case control study in the UK.

Authors: L A García Rodríguez; J Lagergren; M Lindblad
Journal: Gut Date: 2006-06-19 Impact factor: 23.059

2. Gastric acidity before and after the development of carcinoma of the stomach.

Authors: M W COMFORT; M P KELSEY; J BERKSON
Journal: J Natl Cancer Inst Date: 1947-04 Impact factor: 13.506

Review 3. Prevalence of Helicobacter pylori in patients with gastro-oesophageal reflux disease: systematic review.

Authors: Anan Raghunath; A Pali S Hungin; David Wooff; Susan Childs
Journal: BMJ Date: 2003-04-05

Review 4. Campylobacter pyloridis, gastritis, and peptic ulceration.

Authors: C S Goodwin; J A Armstrong; B J Marshall
Journal: J Clin Pathol Date: 1986-04 Impact factor: 3.411

5. Helicobacter pylori infection and the development of gastric cancer.

Authors: N Uemura; S Okamoto; S Yamamoto; N Matsumura; S Yamaguchi; M Yamakido; K Taniyama; N Sasaki; R J Schlemper
Journal: N Engl J Med Date: 2001-09-13 Impact factor: 91.245

6. Gastroesophageal reflux disease, use of H2 receptor antagonists, and risk of esophageal and gastric cancer.

Authors: D C Farrow; T L Vaughan; C Sweeney; M D Gammon; W H Chow; H A Risch; J L Stanford; P D Hansten; S T Mayne; J B Schoenberg; H Rotterdam; H Ahsan; A B West; R Dubrow; J F Fraumeni; W J Blot
Journal: Cancer Causes Control Date: 2000-03 Impact factor: 2.506

Review 7. Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts.

Authors:
Journal: Gut Date: 2001-09 Impact factor: 23.059

Review 8. Cancer of the esophagus and gastric cardia: recent advances.

Authors: G N J Tytgat; H Bartelink; R Bernards; G Giaccone; J J B van Lanschot; G J A Offerhaus; G J Peters
Journal: Dis Esophagus Date: 2004 Impact factor: 3.429

9. Hiatal hernia, reflux symptoms, body size, and risk of esophageal and gastric adenocarcinoma.

Authors: Anna H Wu; Chiu-Chen Tseng; Leslie Bernstein
Journal: Cancer Date: 2003-09-01 Impact factor: 6.860

10. Hiatal hernia size, Barrett's length, and severity of acid reflux are all risk factors for esophageal adenocarcinoma.

Authors: Benjamin Avidan; Amnon Sonnenberg; Thomas G Schnell; Gregorio Chejfec; Adrienne Metz; Stephen J Sontag
Journal: Am J Gastroenterol Date: 2002-08 Impact factor: 10.864

5 in total

Review 1. Why is the coexistence of gastric cancer and duodenal ulcer rare? Examination of factors related to both gastric cancer and duodenal ulcer.

Authors: Hideyuki Ubukata; Hiroyuki Nagata; Takanobu Tabuchi; Satoru Konishi; Teruhiko Kasuga; Takafumi Tabuchi
Journal: Gastric Cancer Date: 2011-01-20 Impact factor: 7.370

2. Network Pharmacology and Molecular Docking Analysis on Pharmacological Mechanisms of Astragalus membranaceus in the Treatment of Gastric Ulcer.

Authors: Piao Zhou; Rui Zhou; Yao Min; Li-Ping An; Fei Wang; Quan-Yu Du
Journal: Evid Based Complement Alternat Med Date: 2022-01-31 Impact factor: 2.629